Live Breaking News & Updates on Biotheryx Inc

Stay updated with breaking news from Biotheryx inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer

/PRNewswire/ BioTheryX, Inc., a clinical-stage company focused on targeted protein degradation to create life-saving medicines, today announced the. ....

New York , United States , New South Wales , South Wales , Philippe Drouet , University Of New South Wales , Biotheryx Inc , Mckinsey Company , Merck Co , Columbia Business School , Sahm Nasseri , Chief Business , Chief Executive Officer , Chief Business Officer , Vice President , Global Product Leader , Chemical Engineering ,

BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer

/PRNewswire/ BioTheryX, Inc., a clinical-stage company focused on targeted protein degradation to create life-saving medicines, today announced the. ....

New York , United States , New South Wales , South Wales , Philippe Drouet , University Of New South Wales , Biotheryx Inc , Mckinsey Company , Merck Co , Columbia Business School , Sahm Nasseri , Chief Business , Chief Executive Officer , Chief Business Officer , Vice President , Global Product Leader , Chemical Engineering ,

Curis Appoints John A. Hohneker, M.D. To Board Of Directors

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today. ....

Evelo Biosciences , Burroughs Wellcome , Johna Hohneker , James Dentzer , Gettysburg College , Curis Inc , Therapeutics Inc , University Of North Carolina At Chapel Hill , Humanigen Inc , Biotheryx Inc , Health Sciences , Global Head Of Development , Rutgers School Of Biomedical , Drug Administration , Aravive Inc , Trishula Therapeutics Inc , Prnewswire Curis Inc , Roche Group , Cygnal Therapeutics Inc , Global Head , Glaxo Wellcome , Rutgers School , North Carolina , Trishula Therapeutics , Cygnal Therapeutics , Orphan Drug Designation ,

BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer

BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace ....

David Stirling , Global Oncology At Merck Co , Biotheryx Inc , Novartis Pharmaceutical Corporation , Mcgill University , Philippe Drouet , Chief Executive Officer , Executive Chairman , Chief Commercial Officer , Senior Vice President , Global Oncology , Global Oncology Marketing , General Manager Oncology , Global Brand Leader , Oncology Marketing , Chemical Engineering , Protein Homeostatic Modulator , Iotheryx Announces Appointment Of Philippe Drouet As Chief Executive Officer ,

Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors

Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Kevin Xie , Ken Trbovich , Burroughs Wellcome , Cameron Durrant , John Hohneker , Gettysburg College , University Of North Carolina At Chapel Hill , Humanigen Inc , Healthcare Holdings For Fosun Group , Biotheryx Inc , Global Head Of Development , Tianjin University , University Of Medicine , Aravive Inc , City University Of New York , Cygnal Therapeutics Inc , Wharton School Of The University Pennsylvania , Company Board Of Directors The , Cygnal Therapeutics , Evelo Biosciences , Trishula Therapeutics , Senior Vice President , Global Head , New Jersey ,